Muscular dystrophy

Last updated: February 23, 2023

Muscular dystrophy

Exam 1 -AHN 548 -

Exam 1 -AHN 548 -

Anatomy of the breast
Anatomy clinical correlates: Breast
Mammary gland histology
Ovary histology
Fallopian tube and uterus histology
Cervix and vagina histology
Anatomy and physiology of the female reproductive system
Puberty and Tanner staging
Estrogen and progesterone
Menstrual cycle
Menopause
Pregnancy
Oxytocin and prolactin
Breastfeeding
Stages of labor
Precocious puberty
Delayed puberty
Klinefelter syndrome
Turner syndrome
5-alpha-reductase deficiency
Androgen insensitivity syndrome
Kallmann syndrome
Amenorrhea
Ovarian cyst
Premature ovarian failure
Ovarian torsion
Polycystic ovary syndrome
Krukenberg tumor
Ovarian sex-cord stromal tumors
Ovarian surface epithelial tumors
Ovarian germ cell tumors
Uterine fibroid
Endometriosis
Endometritis
Endometrial hyperplasia
Choriocarcinoma
Endometrial cancer
Cervical cancer
Pelvic inflammatory disease
Urethritis
Mastitis
Fibrocystic breast changes
Phyllodes tumor
Intraductal papilloma
Paget disease of the breast
Breast cancer
Gestational hypertension
Hyperemesis gravidarum
Preeclampsia & eclampsia
Gestational diabetes
Placenta previa
Placenta previa
Cervical incompetence
Placenta accreta
Placental abruption
Oligohydramnios
Polyhydramnios
Potter sequence
Intrauterine growth restriction
Preterm labor
Postpartum hemorrhage
Chorioamnionitis
Congenital toxoplasmosis
Congenital syphilis
Congenital cytomegalovirus (NORD)
Neonatal conjunctivitis
Neonatal herpes simplex
Neonatal sepsis
Congenital rubella syndrome
Neonatal meningitis
Miscarriage
Gestational trophoblastic disease
Ectopic pregnancy
Fetal alcohol syndrome
Uterine disorders: Pathology review
Cervical cancer: Pathology review
Benign breast conditions: Pathology review
Ovarian cysts and tumors: Pathology review
Vaginal and vulvar disorders: Pathology review
Breast cancer: Pathology review
Complications during pregnancy: Pathology review
Congenital TORCH infections: Pathology review
Amenorrhea: Pathology review
Estrogens and antiestrogens
Androgens and antiandrogens
Uterine stimulants and relaxants
Progestins and antiprogestins
Aromatase inhibitors
Prolactinoma
Breast cancer: Clinical
Abnormal uterine bleeding: Clinical
Cervical cancer: Clinical
Genito-pelvic pain and penetration disorder
Sexual dysfunctions: Clinical
Infertility: Clinical
Amenorrhea: Clinical
Contraception: Clinical
Physical and sexual abuse
Sexual orientation and gender identity
Female sexual interest and arousal disorder
Orgasmic dysfunction
Ovarian cysts, cancer, and other adnexal masses: Clinical
Vulvovaginitis: Clinical
Hypertensive disorders of pregnancy: Clinical
Perinatal infections: Clinical
Gestational trophoblastic disease: Clinical
Routine prenatal care: Clinical
Abnormal labor: Clinical
Neonatal jaundice: Clinical
Streptococcus agalactiae (Group B Strep)
Neonatal hepatitis
Neonatal respiratory distress syndrome
Jaundice
Jaundice: Clinical
Enuresis
Nocturnal enuresis
Elimination disorders: Clinical
Biliary colic
Night terrors
ADHD: Information for patients and families (The Primary School)
Attention deficit hyperactivity disorder
Autism spectrum disorder
Fragile X syndrome
Precocious and delayed puberty: Clinical
Constitutional growth delay
Inheritance patterns
Mendelian genetics and punnett squares
Mitochondrial myopathy
Body dysmorphic disorder
Down syndrome (Trisomy 21)
Edwards syndrome (Trisomy 18)
Patau syndrome (Trisomy 13)
Cri du chat syndrome
DiGeorge syndrome
Williams syndrome
Neurofibromatosis
Marfan syndrome
Achondroplasia
Osteogenesis imperfecta
Craniosynostosis
Myelodysplastic syndromes
Cystic fibrosis
Cystic fibrosis: Pathology review
Cystic fibrosis: Clinical
Alport syndrome
Spinal muscular atrophy
Muscular dystrophy
Hemophilia
Prader-Willi syndrome
Angelman syndrome
Beckwith-Wiedemann syndrome
Acute intermittent porphyria
Familial hypercholesterolemia
Gaucher disease (NORD)
Cleft lip and palate
Spina bifida
Developmental milestones: Clinical

Transcript

Watch video only

Content Reviewers

With muscular dystrophy, “dys” means bad or difficult, and “troph” means nourish; so muscular dystrophy basically refers to the muscle appearing poorly nourished because of degeneration, which leads to muscle weakness.

Under a microscope, a biopsy of the tissue shows changes in the muscle itself but not in the nerve or neuromuscular junction; this distinguishes muscular dystrophy from other problems that cause muscle weakness as a result of nerve damage, like neuropathies.

Muscular dystrophy is actually a group of disorders, all of which are caused by genetic mutations.

Within that group, dystrophinopathies are the most common, which includes Duchenne muscular dystrophy, or DMD, and Becker muscular dystrophy, both of which result from mutations in the dystrophin gene.

In addition to those two, genetic mutations in other genes are responsible for several dozen other muscular dystrophies, some of which code for proteins that form a protein complex with dystrophin protein.

These other muscular dystrophies, therefore end up causing a lot of the same symptoms as the dystrophinopathies.

Now, the fact that both Duchenne and Becker muscular dystrophy result from mutations in the same dystrophin gene means that they are “allelic disorders,” and when a mutation occurs in dystrophin that’s severe enough to result in no protein at all, for example a nonsense or a frameshift mutation, the result is Duchenne muscular dystrophy, which ends up being the more severe of the two, with symptoms usually presenting by age 5.

On the other hand, mutations that allow for a misshapen protein to form, like missense mutations, lead to Becker muscular dystrophy which is basically a milder form of Duchenne muscular dystrophy that presents later on, usually between age 10 to 20.

Alright so the dystrophin gene is a huge gene on the X-chromosome, that has 79 exons and is over 2 million base pairs in length.

By comparison, most genes have only about 10 exons and are 50 thousand base pairs in length.

More base pairs and more exons mean that there are more chances for mistakes during meiosis, which is when the egg or sperm are being created.

Most of these gene mutations are deletions or duplications of one or more exons, and a small amount are point mutations.

Now males males have one X and one Y chromosome, and females have two X chromosomes.

This means it’s way more common in boys, because they only have one copy of the dystrophin gene, and if that copy’s defective, it’s the only one available to muscle cells, whereas girls with a defective dystrophin gene might have another functional one.

Since this is linked to the X chromosome, both Duchenne and Becker muscular dystrophy are called X-linked recessive.

In females, though, only one X chromosome gets expressed, and the other is inactivated, called X-inactivation or lyonization.

Now if this inactivation’s random, you’d expect about half of the female’s cells to have a functional dystrophin gene and the other half to have a defective dystrophin gene, and these people are typically asymptomatic.

Having said that, if more cells end up with the defective dystrophin gene, and less with the functional one, they can end up being “manifesting carriers,” meaning that they manifest or show some symptoms.

Key Takeaways

Muscular dystrophy is a group of inherited diseases that cause progressive weakness and degeneration of the skeletal muscles that control movement (e.g. Duchenne and Becker muscular dystrophy). Muscular dystrophy is caused by genetic defects that interfere with the production of proteins needed to form healthy muscle. There is currently no cure for muscular dystrophy, physical and occupational therapy, and medications can help manage the symptoms and slow the progression of the disease.